Clonidine or placebo added to stimulant treatment for ADHD in children and teens
About this title
Read the official source — NCT00641329This study evaluated the safety and effectiveness of CLONICEL (clonidine HCl sustained release) for people with ADHD.
Understand this study
What did researchers investigate?
This study evaluated the safety and effectiveness of CLONICEL (clonidine HCl sustained release) for people with ADHD.
Who was this study for?
This study was for people with ADHD. Listed age limits: 6 years to 17 years. Other eligibility criteria applied.
- Listed locations
- Little Rock and 22 more locationsSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
- Recruitment status
- Completed
- Enrollment listed in the registry
- 198
- Sponsor
- Addrenex Pharmaceuticals, Inc.
- Sponsor type
- Other organization
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- From 6 Years to 17 Years
- Official registry ID
- NCT00641329
- Official title
Show the full official title
Phase III Evaluation of the Safety and Efficacy of CLONICEL (Clonidine HCl Sustained Release) as Add-on to Psychostimulant Medication vs. Psychostimulant Medication Alone in Children and Adolescents With ADHD
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
Little Rock · El Centro · Irvine
18 more locations
- San Diego
- Bradenton
- Lauderhill
- Miami
- Bardstown
- Baltimore
- St Louis
- Clementon
- Chapel Hill
- Durham
- Cleveland
- Oklahoma City
- Houston
- Lake Jackson
- Wharton
- Clinton
- Kirkland
- Spokane
Interested in joining this study?
Questions about this study
What did researchers investigate?
This study evaluated the safety and effectiveness of CLONICEL (clonidine HCl sustained release) for people with ADHD.
Who is behind this study?
The study sponsor is Addrenex Pharmaceuticals, Inc.
Did this study involve medication?
Yes. The study involved medication, including CLONICEL (clonidine HCl sustained release) and Placebo.
Who was this study for?
This study was for people with ADHD. Listed age limits: 6 years to 17 years. Other eligibility criteria applied.
